First New York Securities’s PharMerica Corporation PMC Stock Holding History

First New York Securities’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500	Closed	-$14K	–	244
2016 Q3	$14K	Buy	+500	New	+$12.8K	0.01%	184

Other funds holding PMC

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First New York Securities's PMC Position: Q4 2016 in Review

First New York Securities sold out of PharMerica Corporation (PMC) in Q4 2016, closing a stake of 500 shares — an estimated $14K sold.

First New York Securities first reported a position in PMC in Q3 2016 and held it in 1 quarter. The position peaked at $14K in Q3 2016. 166 funds tracked by Wall St. Rank hold PMC as of Q4 2016.

First New York Securities reported no remaining PharMerica Corporation position as of Q4 2016 after selling out during the quarter.
First New York Securities sold 500 PharMerica Corporation shares in Q4 2016, an estimated $14K.
First New York Securities first reported a position in PharMerica Corporation in Q3 2016 and held it in 1 quarter.
First New York Securities's PharMerica Corporation position peaked at $14K in Q3 2016.
166 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.